Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.3.2.31: RBR-type E3 ubiquitin transferase

This is an abbreviated version!
For detailed information about RBR-type E3 ubiquitin transferase, go to the full flat file.

Word Map on EC 2.3.2.31

Reaction

[E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine
+
[acceptor protein]-L-lysine
=
[E2 ubiquitin-conjugating enzyme]-L-cysteine
+
[acceptor protein]-N6-ubiquitinyl-L-lysine

Synonyms

ARIH1, ARIH2, HHARI, HOIP, Parkin, parkin RBR E3 ubiquitin ligase, PRKN, RBR E3, RBR-type E3, RBR-type E3 ligase, RBX1, RFA1, RFA4, RING Finger ABA-Related, RNF144, RNF144A, RNF144AA, RNF144AB, RNF144B, RNF19A, RNF19B, RNF217, RNF31, Triad1

ECTree

     2 Transferases
         2.3 Acyltransferases
             2.3.2 Aminoacyltransferases
                2.3.2.31 RBR-type E3 ubiquitin transferase

Engineering

Engineering on EC 2.3.2.31 - RBR-type E3 ubiquitin transferase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
C361A
-
mutation in isoform RFA4, affects its own ubiquitination and capability to ubiquitinate PYL4
A46P
parkin disease mutant, loss of activity
C357A
the mutant shows wild type activity
C431F
parkin disease mutant, loss of activity
C431S/H433A
RING2 mutant, able to trap the catalytic parkin-ubiquitin intermediate
E321A/C431S/H433A
UBR2 patch mutant of parkin. In contrast to C431S/H433A, this mutant is defective in ubiquitin charging even in the presence of phosphoubiquitin
E352A
moderate reduction of ubiquitination activity
G430D
parkin disease mutant, loss of activity
H302A/E321A/C431S/H433A
60fold reduced in ubiquitin charging of the RING2
H359A
catalytic loop mutant
I188A
inactive
K161N
parkin disease mutant, loss of activity
K211N
parkin disease mutant, loss of activity
K27N
parkin disease mutant, 0.7fold reduction in activity
N358A
catalytic loop mutant
R275W
parkin disease mutant, loss of activity
R363A
no observable effect
R42P
parkin disease mutant, 2.2fold activation of activity
S65A
parkin disease mutant, loss of activity
T341N
mimic of mutant T415N in parkin, decreases HHARI's ligase activity substantially
T415N
parkin disease mutant, loss of activity
W336A
moderate reduction of ubiquitination activity
additional information